PL3374024T3 - Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego - Google Patents

Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego

Info

Publication number
PL3374024T3
PL3374024T3 PL16863657.9T PL16863657T PL3374024T3 PL 3374024 T3 PL3374024 T3 PL 3374024T3 PL 16863657 T PL16863657 T PL 16863657T PL 3374024 T3 PL3374024 T3 PL 3374024T3
Authority
PL
Poland
Prior art keywords
kit
brain tumor
ultrasound system
treating brain
treating
Prior art date
Application number
PL16863657.9T
Other languages
English (en)
Inventor
Hao-Li Liu
Po-Chun Chu
Ting-Kuang CHANG
Kuo-Chen Wei
Pin-Yuan Chen
Chiung-Yin Huang
Original Assignee
Navifus Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Navifus Co., Ltd. filed Critical Navifus Co., Ltd.
Publication of PL3374024T3 publication Critical patent/PL3374024T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36—Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37—Surgical systems with images on a monitor during operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N7/02—Localised ultrasound hyperthermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0021—Neural system treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0039—Ultrasound therapy using microbubbles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PL16863657.9T 2015-11-11 2016-11-10 Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego PL3374024T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562253805P 2015-11-11 2015-11-11
PCT/CN2016/105293 WO2017080481A1 (en) 2015-11-11 2016-11-10 Method and kit for treating brain tumor by using ultrasound system

Publications (1)

Publication Number Publication Date
PL3374024T3 true PL3374024T3 (pl) 2022-12-12

Family

ID=58694540

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16863657.9T PL3374024T3 (pl) 2015-11-11 2016-11-10 Sposób i zestaw do leczenia nowotworu mózgu za pomocą systemu ultradźwiękowego

Country Status (11)

Country Link
US (1) US20210106849A1 (pl)
EP (1) EP3374024B1 (pl)
JP (1) JP7053463B2 (pl)
CN (1) CN108430579B (pl)
AU (1) AU2016354728B2 (pl)
DK (1) DK3374024T3 (pl)
ES (1) ES2925002T3 (pl)
HU (1) HUE059596T2 (pl)
PL (1) PL3374024T3 (pl)
TW (1) TWI751122B (pl)
WO (1) WO2017080481A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE060034T2 (hu) 2013-09-27 2023-01-28 Exact Therapeutics As Ultrahanggal közvetített hatóanyag leadás
HK1251190A1 (zh) 2014-12-19 2019-01-25 皮埃尔与玛丽‧居里-巴黎第六大学 用於脑治疗的可植入的超声发生治疗装置、包括此装置的设备以及实施此装置的方法
EP3426347B1 (en) 2016-03-11 2024-05-15 Sorbonne Universite Implantable ultrasound generating treating device for spinal cord treatment and apparatus comprising such device
CN109414243B (zh) 2016-03-11 2022-03-29 索邦大学 用于脊髓和脊神经治疗的外部超声波生成治疗装置、包括该装置的设备和实施该装置的方法
EP3840840A1 (en) * 2018-08-23 2021-06-30 Siwa Corporation Anti carboxymethyl lysine antibodies and ultrasound for removing age-modified cells
WO2020211076A1 (zh) * 2019-04-19 2020-10-22 深圳先进技术研究院 一种实现超声穿颅聚焦的方法以及电子设备
EP3957299A1 (en) * 2020-08-17 2022-02-23 ETH Zurich Localized delivery of diagnostic or therapeutic agents using focused ultrasound
CN117120028A (zh) * 2020-11-03 2023-11-24 维塞隆公司 使用载剂靶向递送治疗剂的组合物和方法
GB2605422B (en) * 2021-03-31 2025-04-30 Act Therapeutics Ltd Treatment of the central nervous system
NO20221187A1 (en) 2022-11-04 2024-05-06 Exact Therapeutics As Method and system for calculating a point estimate of an ultrasound dose

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5752515A (en) * 1996-08-21 1998-05-19 Brigham & Women's Hospital Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier
US7896821B1 (en) * 2003-11-14 2011-03-01 Perfusion Technology, LLC Low intensity directed ultrasound (LODUS) mediated blood brain barrier disruption
US7674229B2 (en) 2005-03-07 2010-03-09 The Brigham And Women's Hospital, Inc. Adaptive ultrasound delivery system
US8084027B2 (en) * 2006-02-10 2011-12-27 Nerviano Medical Sciences S.R.L. Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic
CA2655411A1 (en) * 2006-06-15 2007-12-21 Biogen Idec Ma Inc. Combination therapy employing lymphotoxin beta receptor binding molecules in combination with second agents
US20100203048A1 (en) * 2008-04-30 2010-08-12 Stephen Evans-Freke Methods of using corticotropin-releasing factor for the use of the treatment of cancer
TWI382860B (zh) * 2008-07-11 2013-01-21 Univ Chang Gung 非侵入式低頻超音波腦部治療裝置及其使用方法
US20110125080A1 (en) 2008-07-23 2011-05-26 Koninklijke Philips Electronics N.V. Ultrasound mediated drug delivery
US20100143241A1 (en) * 2008-10-22 2010-06-10 Johnson G Allan Method and apparatus for delivery of agents across the blood brain barrier
WO2011101039A1 (en) * 2010-02-22 2011-08-25 Universite Pierre Et Marie Curie (Paris 6) Apparatus for the treatment of brain affections and method implementing thereof
US20130251633A1 (en) * 2010-08-05 2013-09-26 The Trustees Of Columbia University In The City Of New York Systems, methods, and devices for ultrasonic assessment of cancer and response to therapy
US20120095325A1 (en) 2010-10-15 2012-04-19 Chang Gung Medical Foundation, Linkou Branch Treatment of brain diseases via ultrasound/magnetic targeting delivery and tracing of therapeutic agents
GB201019434D0 (en) 2010-11-17 2010-12-29 Isis Innovation Sonosensitive nanoparticles
RU2013131168A (ru) 2010-12-09 2015-01-20 Ф. Хоффманн-Ля Рош Аг Agtr1 в качестве маркера для комбинированных терапий с использованием бевацизумаба
WO2012162664A1 (en) * 2011-05-26 2012-11-29 The Trustees Of Columbia University In The City Of New York Systems and methods for opening of a tissue barrier in primates
US10275680B2 (en) * 2011-10-19 2019-04-30 Tel Hashomer Medical Research Infrastructure And Services Ltd. Magnetic resonance maps for analyzing tissue
CN102525935A (zh) * 2012-01-18 2012-07-04 上海交通大学医学院 一种纳米药物载体脑内递送方法
US9149455B2 (en) * 2012-11-09 2015-10-06 Abraxis Bioscience, Llc Methods of treating melanoma
HUE060034T2 (hu) 2013-09-27 2023-01-28 Exact Therapeutics As Ultrahanggal közvetített hatóanyag leadás
WO2015192189A1 (en) * 2014-06-20 2015-12-23 The University Of Queensland Neurodegenerative disease treatment
WO2017004562A1 (en) * 2015-07-01 2017-01-05 The Trustees Of Columbia University In The City Of New York Systems and methods for modulation and mapping of brain tissue using an ultrasound assembly

Also Published As

Publication number Publication date
TWI751122B (zh) 2022-01-01
AU2016354728A1 (en) 2018-05-24
CN108430579A (zh) 2018-08-21
TW201729866A (zh) 2017-09-01
DK3374024T3 (da) 2022-08-15
EP3374024A4 (en) 2019-06-19
US20210106849A1 (en) 2021-04-15
ES2925002T3 (es) 2022-10-13
CN108430579B (zh) 2021-02-05
HUE059596T2 (hu) 2022-12-28
HK1256135A1 (zh) 2019-09-13
EP3374024A1 (en) 2018-09-19
JP2019502657A (ja) 2019-01-31
EP3374024B1 (en) 2022-07-13
WO2017080481A1 (en) 2017-05-18
AU2016354728B2 (en) 2019-02-28
JP7053463B2 (ja) 2022-04-12

Similar Documents

Publication Publication Date Title
ZA201705673B (en) Methods for treating skin
IL250329A0 (en) System and method for optogenetic therapy
ZA201701491B (en) Methods and therapeutic combinations for treating tumors
ZA201706616B (en) Method for treating cancer
ZA201703290B (en) Methods for tumor treatment using cd3xcd20 bispecific antibody
SG10201913409VA (en) Methods for solid tumor treatment
HUE059596T2 (hu) Agydaganat kezelésének módszere és készlete ultrahangos rendszer segítségével
IL257691A (en) A method for treating cancer
IL256836B (en) Methods for treating cancer using apilimod
IL254014B (en) System and method for water treatment
PT3322827T (pt) Método melhorado para curtimento de pele de animal.
SG10201508795XA (en) Method for treating cancer
ZA202001927B (en) Method for treating tnf alpha-related diseases
GB2537603B (en) Method and apparatus for water treatment
IL255012A0 (en) Preparations and methods for treating skin conditions
ZA201607027B (en) Method for treating or enhancing muscle tissue
GB2594828B (en) Method and apparatus for water treatment
EP3325125A4 (en) Method and apparatus for water treatment
HK1237665A1 (en) Methods and therapeutic combinations for treating tumors
GB201501202D0 (en) Novel methods for diagnosis and therapy
GB201507268D0 (en) Method for stimulating aerogenosis